GTT: Main terms and conditions of the share buy-back

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
48
GTT: Main terms and conditions of the share buy-back programme adopted by the Board of directors of GTT on May 18, 2017

GAZTRANSPORT & TECHNIGAZ Société anonyme with a share capital of €370,783.57 Registered office: 1 route de Versailles - 78470 Saint-Rémy-lès-Chevreuse, France 662 001 403 R.C.S. Versailles

Main terms and conditions of the share buy-back programme adopted by the Board of directors of GTT on May 18, 2017 and published in accordance with the conditions and obligations set by Articles 241-1 and seq. of the General Regulations of the Autorité des marchés financiers (AMF)

Implementation of the share buy-back programme authorised by the Combined Shareholders' meeting on May 18, 2017

Issuer : GTT / ISIN code: FR 0011726835 (compartment A)

Stock concerned  : Ordinary shares

Implementation authorized by : Combined Shareholders' meeting on May 18, 2017

Implementation decision date : May 18, 2017

Maximum proportion of the share capital that may be acquired pursuant to the Shareholders' authorization : 10% of the number of ordinary shares composing GTT's share capital, or, for indicative purposes 3,707,835 shares on the basis of the capital as at December 31, 2016. It is specified that: (i)         the acquired shares for the retaining and later delivery(in exchange, payment or other) as part of an acquisition transaction, limited to 5% of the capital; (ii)        when the shares are bought back to stimulate trading as part of a liquidity contract, the number of shares taken into account for the calculation of the 10% limit corresponds to the number of shares purchased, less the number of shares sold back over the period of the authorization ; (iii)       the Company may not directly or indirectly own more than 10% of its capital.

Maximum purchase price : €60 per share (fees not included)

Maximum amount of purchases authorized by the programme: €20,000,000.

Objectives of the programme :

  • the allocation or sale of shares to employees or corporate officers of the Company or Group companies under the conditions and in accordance with the procedures allowed by law, notably with respect to company profit-sharing, or the allocation of free shares, or in the case of share purchase options, or as part of a group savings scheme or any other company savings scheme existing in the Group;
  • the delivery of shares upon the exercise of rights attached to securities giving right to repayment, conversion, exchange, presentation of a warrant, or any other means of allocating shares of the Company;
  • more generally, to honour the obligations linked to share option programs or other plans for allocation of shares to employees or corporate officers or those of an associated company;
  • the retaining and later delivery of shares (in exchange, payment or other) as part of an acquisition transaction, limited to 5% of the number of shares comprising the share capital;
  • the cancellation of all or a part of the shares bought back; and
  • the stimulation of the secondary market or the liquidity of the shares by an investment services provider acting under a liquidity contract in compliance with the code of ethics recognised by the AMF.

This share buyback programme would also be intended to allow the Company to operate for any other authorised purpose or purpose that would be authorised by any applicable laws or regulations in force and to implement any practice that would be allowed by the AMF. In such event, the Company would inform its shareholders through a press release.

The Board of Directors may use this authorisation at any time, within the limits authorised by legal and regulatory provisions and carry out the share buyback programme in the case of a public offering in strict compliance with the provisions of Article 231-41 of the General Regulation of the AMF and of Article L. 225-209 of the French Commercial Code. The acquisition, transfer or disposal of shares could be carried out, on one or more occasions, by any means authorised by applicable laws or regulations, including over-the-counter transactions, the trading of blocks of securities for all or part of the programme and the use of any derivative financial instrument.

Programme duration : from the release of this description of the programme and until November 17, 2018, i.e. a period of 18 months as from the date of the Shareholders' Meeting dated May 18, 2017.

Breakdown of the treasury shares held as at May 19, 2017 by objective : At May 19, 2017, the Company held 17,457 GTT shares, representing 0.05% of the share capital pursuant to a liquidity agreement signed with Exane to make a market in GTT shares, and compliant with the AMAFI ethical charter recognised by the AMF, and 3,103 shares, representing 0.01% of the share capital pursuant to a share buy-back agreement.

This document is published, in accordance with the AMF General Regulations, on May 22, 2017 prior to the implementation of the programme.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...d05cfd1a9d

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 545

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 117

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 40

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 158

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 271

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 206

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 652

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 309

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 112

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 115

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on 74Software's Voting Rights and Share Capital Details

Updated Category News Views 182

Understanding Voting Rights and Share Capital of 74Software In a recent communication, 74Software shared vital information regarding its voting rights and total share capital. As a company with a rich background in enterprise software, they remain committed to transparency with their shareholders. Highlights of Total Shares As of August 31, 2025, the total number of...

Continue Reading
Tenon Medical Earnings Report: Insights and Predictions Ahead

Updated Category News Views 125

Insights into Tenon Medical's Upcoming Earnings As the market anticipates the upcoming earnings release from Tenon Medical Inc (NASDAQ: TNON), investors are eager to understand what the future holds for the company. While the earnings date is set, the focus is largely on the earnings per share (EPS) forecasted at $-0.47. This brings both concern and hope as stakeholders...

Continue Reading
Cahill's New Counsel James Mandolfo Strengthens Investigations Team

Updated Category News Views 95

Cahill's New Counsel James Mandolfo Strengthens Investigations Team Cahill Gordon & Reindel LLP, a prestigious law firm known for its expertise and long-standing reputation in the legal field, has recently added James Mandolfo to its team. As part of the Congressional Investigations and White Collar Defense & Investigations practices, James brings a wealth of knowledge...

Continue Reading
Capstone Infrastructure Unveils Landmark Wind Projects with Partners

Updated Category News Views 311

Capstone Infrastructure's New Renewable Energy Initiatives Toronto, Ontario — Capstone Infrastructure Corporation (TSX: CSE.PR.A) is excited to share its involvement in three critical wind energy projects in collaboration with Indigenous partners. These projects highlight the Corporation's commitment to sustainable energy solutions and community empowerment....

Continue Reading
Investigation Raises Questions for Encompass Health Investors

Updated Category News Views 211

Investigation into Encompass Health Corporation Pomerantz LLP is currently conducting an investigation on behalf of investors in Encompass Health Corporation (NYSE: EHC). This investigation aims to uncover whether there have been any incidents of securities fraud or other unlawful business practices involving the company and its executives. Allegations of Unlawful...

Continue Reading